Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Cervical Cancer

  Free Subscription


1 Am J Obstet Gynecol
1 Anticancer Res
1 Br J Radiol
1 Diagn Cytopathol
1 Eur J Public Health
1 Ginekol Pol
1 Gynecol Oncol
1 Hum Vaccin Immunother
1 Int J Cancer
1 J Cell Biochem
1 J Cell Physiol
1 J Virol
1 Minim Invasive Ther Allied Technol
1 Nurs Health Sci
2 Photodiagnosis Photodyn Ther
1 Prev Med
1 Radiol Med
1 Zhonghua Fu Chan Ke Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Obstet Gynecol

  1. ALMASI-HASHIANI A, Ayubi E, Safiri S
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer: Methodological issues.
    Am J Obstet Gynecol. 2017 Oct 17. pii: S0002-9378(17)31203.
    PubMed     Text format    

    Anticancer Res

  2. TRYBUS W, Krol T, Trybus E, Kopacz-Bednarska A, et al
    Changes in the Lysosomal System of Cervical Cancer Cells Induced by Emodin Action.
    Anticancer Res. 2017;37:6087-6096.
    PubMed     Text format     Abstract available

    Br J Radiol

  3. NARAYANAN P, Sahdev A
    The role of 18F-FDG PET CT in Common Gynaecological Malignancies.
    Br J Radiol. 2017 Aug 22:20170283. doi: 10.1259/bjr.20170283.
    PubMed     Text format     Abstract available

    Diagn Cytopathol

  4. KIM HJ, Kim CY, Jin J, Bae MK, et al
    Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.
    Diagn Cytopathol. 2017 Oct 24. doi: 10.1002/dc.23838.
    PubMed     Text format     Abstract available

    Eur J Public Health

  5. MENDES D, Mesher D, Pista A, Baguelin M, et al
    Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England.
    Eur J Public Health. 2017 Oct 20. doi: 10.1093.
    PubMed     Text format     Abstract available

    Ginekol Pol

  6. PLACHTA M, Cholewinski W, Burchardt E, Cegla P, et al
    Strategy and early results of treatment of advanced cervical cancer patients with synchronous cancers observed in PET-CT imaging.
    Ginekol Pol. 2017;88:475-480.
    PubMed     Text format     Abstract available

    Gynecol Oncol

  7. YAMAMOTO K, Nagao S, Suzuki K, Kogiku A, et al
    Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.
    Gynecol Oncol. 2017 Oct 18. pii: S0090-8258(17)31359.
    PubMed     Text format     Abstract available

    Hum Vaccin Immunother

  8. PAOLINI F, Curzio G, Cordeiro MN, Massa S, et al
    HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.
    Hum Vaccin Immunother. 2017;13:291-297.
    PubMed     Text format     Abstract available

    Int J Cancer

  9. MATSUZAKI S, Serada S, Hiramatsu K, Nojima S, et al
    Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31124.
    PubMed     Text format     Abstract available

    J Cell Biochem

  10. LIU Y, Li L, Liu Y, Geng P, et al
    RECK inhibits cervical cancer cell migration and invasion by promoting p53 signaling pathway.
    J Cell Biochem. 2017 Oct 24. doi: 10.1002/jcb.26441.
    PubMed     Text format     Abstract available

    J Cell Physiol

  11. BOROMAND N, Hasanzadeh M, Sales SS, Farazestanian M, et al
    Clinical and Prognostic Value of the C-Met/HGF Signaling Pathway in Cervical Cancer.
    J Cell Physiol. 2017 Oct 23. doi: 10.1002/jcp.26232.
    PubMed     Text format     Abstract available

    J Virol

  12. WALLACE NA, Khanal S, Robinson KL, Wendel SO, et al
    High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available

    Minim Invasive Ther Allied Technol

  13. YIN G, Li J, Wu A, Liang J, et al
    Four categories of LEEP for CIN of various areas: a retrospective cohort study.
    Minim Invasive Ther Allied Technol. 2017;26:104-110.
    PubMed     Text format     Abstract available

    Nurs Health Sci

  14. ALI S, Skirton H, Clark MT, Donaldson C, et al
    Integrative review of cervical cancer screening in Western Asian and Middle Eastern Arab countries.
    Nurs Health Sci. 2017 Oct 23. doi: 10.1111/nhs.12374.
    PubMed     Text format     Abstract available

    Photodiagnosis Photodyn Ther

  15. DANIEL A, P A, Ganesan S, Joseph L, et al
    Biochemical assessment of human uterine cervix by micro-Raman mapping.
    Photodiagnosis Photodyn Ther. 2017;17:65-74.
    PubMed     Text format     Abstract available

  16. HASS R, Jacobs R, Kaufmann AM, Hillemanns P, et al
    Sensitization of immune cells following hexylaminolevulinate photodynamic therapy of cervical intraepithelial neoplasia.
    Photodiagnosis Photodyn Ther. 2017;17:82-86.
    PubMed     Text format     Abstract available

    Prev Med

  17. SCHIFFMAN M, Wentzensen N
    Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions.
    Prev Med. 2017;105:378-380.
    PubMed     Text format     Abstract available

    Radiol Med

  18. WOO S, Kim SY, Cho JY, Kim SH, et al
    Apparent diffusion coefficient for prediction of parametrial invasion in cervical cancer: a critical evaluation based on stratification to a Likert scale using T2-weighted imaging.
    Radiol Med. 2017 Oct 20. doi: 10.1007/s11547-017-0823.
    PubMed     Text format     Abstract available

    Zhonghua Fu Chan Ke Za Zhi

  19. DU XX, Yang H, Zhang HJ, Li LA, et al
    [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:679-686.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.